Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dendritic cell paucity in mismatch repair–proficient colorectal cancer liver metastases limits immune checkpoint blockade efficacy
William W. Ho, Igor L. Gomes‐Santos, Shuichi Aoki, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 45
Open Access | Times Cited: 63

Showing 26-50 of 63 citing articles:

Ionizing Radiation Drives Key Regulators of Antigen Presentation and a Global Expansion of the Immunopeptidome
Arun Tailor, Hala Estephan, Robert Parker, et al.
Molecular & Cellular Proteomics (2022) Vol. 21, Iss. 11, pp. 100410-100410
Open Access | Times Cited: 13
BRD4 inhibition impairs DNA mismatch repair, induces mismatch repair mutation signatures and creates therapeutic vulnerability to immune checkpoint blockade in MMR-proficient tumors
Yu Fu, Bin Yang, Yaoyuan Cui, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 4, pp. e006070-e006070
Open Access | Times Cited: 7
Combination CXCR4 and PD1 blockade enhances intratumoral dendritic cell activation and immune responses against hepatocellular carcinoma
Satoru Morita, Pin‐Ji Lei, Kohei Shigeta, et al.
Cancer Immunology Research (2024) Vol. 13, Iss. 2, pp. 162-170
Closed Access | Times Cited: 2
Spatially organized tumor-stroma boundary determines the efficacy of immunotherapy in colorectal cancer patients
Yu Feng, Wenjuan Ma, Yupeng Zang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Leveraging immune resistance archetypes in solid cancer to inform next-generation anticancer therapies
Kristin G. Anderson, David A. Braun, Aitziber Buqué, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 6, pp. e006533-e006533
Open Access | Times Cited: 6
Impact of immune tolerance mechanisms on the efficacy of immunotherapy in primary and secondary liver cancers
K. Nathan Sankar, Ashley N. Pearson, Tejaswi Worlikar, et al.
Translational Gastroenterology and Hepatology (2023) Vol. 8, pp. 29-29
Open Access | Times Cited: 6
Enhanced antitumour response of gold nanostar-mediated photothermal therapy in combination with immunotherapy in a mouse model of colon carcinoma
Hsin‐Hua Hsieh, Chuan-Lin Chen, Hui-Wen Chan, et al.
British Journal of Cancer (2023) Vol. 130, Iss. 3, pp. 406-416
Closed Access | Times Cited: 5
Prognostic risk analysis related to radioresistance genes in colorectal cancer
Haoren Qin, Heng Zhang, Haipeng Li, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 4
Clinical significance and changes to the immune microenvironment of colorectal cancer patients with liver metastasis
Ting Wang, Long Tang, Bing Ouyang, et al.
Journal of Gastrointestinal Oncology (2023) Vol. 14, Iss. 1, pp. 206-212
Open Access | Times Cited: 4
Cell Replacement Therapy for Brain Repair: Recent Progress and Remaining Challenges for Treating Parkinson’s Disease and Cortical Injury
Paul M. Harary, Dennis Jgamadze, Jaeha Kim, et al.
Brain Sciences (2023) Vol. 13, Iss. 12, pp. 1654-1654
Open Access | Times Cited: 4
Treatment strategies and molecular mechanism of radiotherapy combined with immunotherapy in colorectal cancer
Yuzhao Jin, Jin Jiang, Wei Mao, et al.
Cancer Letters (2024) Vol. 591, pp. 216858-216858
Open Access | Times Cited: 1
Complete response of metastatic microsatellite-stable BRAF V600E colorectal cancer to first-line oxaliplatin-based chemotherapy and immune checkpoint blockade
Anne Hansen Ree, Eirik Høye, Ying Esbensen, et al.
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Mismatch repair-proficient tumor footprints in the sands of immune desert: mechanistic constraints and precision platforms
Biswanath Majumder, Nishanth Belugali Nataraj, Leela Maitreyi, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Cellular mechanisms of combining innate immunity activation with PD-1/PD-L1 blockade in treatment of colorectal cancer
Qi Xie, Xiaolin Liu, Rengyun Liu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 1
TNIK Inhibition Has Dual Synergistic Effects on Tumor and Associated Immune Cells
Jaehee Kim, Juhyun Oh, Hannah Peterson, et al.
Advanced Biology (2022) Vol. 6, Iss. 8
Open Access | Times Cited: 7
Strategies to Optimize Treatment for Locally Advanced Rectal Cancer
Xiaoyu Hu, Zhuang Xue, Kewen He, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 219-219
Open Access | Times Cited: 7
Regorafenib with or without a programmed cell death protein 1 antibody as third‐line treatment for microsatellite stable metastatic colorectal cancer
Wenzhuo He, Lei Wang, Chenxi Yin, et al.
Cancer Medicine (2022) Vol. 12, Iss. 6, pp. 6488-6498
Open Access | Times Cited: 7
Inhibition of Angiogenesis and Extracellular Matrix Remodeling: Synergistic Effect of Renin-Angiotensin System Inhibitors and Bevacizumab
Tianshu Ren, Hui Jia, Qiong Wu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 6
Vaccination and Microbiota Manipulation Approaches for Colon Cancer Prevention in Rodent Models
Elena Tosti, Nityanand Srivastava, Winfried Edelmann
Cancer Prevention Research (2023) Vol. 16, Iss. 8, pp. 429-438
Closed Access | Times Cited: 3
Evaluation of the Prognostic Role of Liver Metastases on Patient Outcomes
Jessica Waninger, Vincent Ma, Zoey Chopra, et al.
The Cancer Journal (2023) Vol. 29, Iss. 5, pp. 279-284
Open Access | Times Cited: 3
Ataluren suppresses a premature termination codon in an MPS I-H mouse
Dan Wang, Xiaojiao Xue, Gwen Gunn, et al.
Journal of Molecular Medicine (2022) Vol. 100, Iss. 8, pp. 1223-1235
Open Access | Times Cited: 5
Early radiologic signal of responsiveness to immune checkpoint blockade in microsatellite-stable/mismatch repair-proficient metastatic colorectal cancer
Sebastian Meltzer, Anne Negård, Kine Mari Bakke, et al.
British Journal of Cancer (2022) Vol. 127, Iss. 12, pp. 2227-2233
Open Access | Times Cited: 5
Antigen-loaded Monocyte Administration and Flt3 Ligand Augment the Antitumor Efficacy of Immune Checkpoint Blockade in a Murine Melanoma Model
Vincent M. D’Anniballe, Min-Nung Huang, Benjamin D. Lueck, et al.
Journal of Immunotherapy (2023) Vol. 46, Iss. 9, pp. 333-340
Open Access | Times Cited: 2
The prognostic and immune significance of SLAMF9 in pan-cancer and validation of its role in colorectal cancer
Chunmei Zhao, Xingjia Zhu, Huimin Liu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Shengqiyichang Decoction regulates antitumor immunity in colorectal cancer by downregulating lymphocyte antigen 6 family member G6D via the protein kinase B/p38 mitogen-activated protein kinase signaling pathway
Run Xing Luo, Huai Liang Li, Yu Jia, et al.
Heliyon (2024) Vol. 10, Iss. 21, pp. e39071-e39071
Open Access

Scroll to top